A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin–docetaxel, plus radical concurrent chemoradiotherapy with cisplatin–docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer

Suresh Senan, F. Cardenal, Johan Vansteenkiste et al. · Annals of Oncology · 2010

Cited by 35 works. doi:10.1093/annonc/mdq388

Authors

References